VI. 12. What To Do Now

This closing chapter turns the whole book into action: key takeaways built on four foundations — fiber, sleep, movement, stress management — plus profile-based step lists and a 30-day plan, so you can start with a single step tomorrow.

After eleven chapters, it's worth putting the book down and actually doing something. That's the purpose of this chapter: not new information, but a summary and action guide — by profile. You choose the path that applies to you.

Key takeaways (one page)

The essence of the whole book in 10 sentences:

1. Your microbiome changes every single day — meals, sleep, stress, and movement noticeably affect it within 24–48 hours.
2. Diversity is key. The problem isn't the absence of a single "good" bacterium but a decline in species variety and a disruption of their relative proportions. 30+ plant species per week is the best diversity-improving measure.
3. The disease–microbiota link sits on four tiers (): recurrent C. difficile is treatable via microbiota-directed therapy (FMT, RCT-grade), but autism or Parkinson's microbiome "modulation" is still hypothesis-level and requires case-by-case consideration. Know where you stand on the evidence map.
4. Nutrition is your strongest lever. Fiber (25–35 g/day), 5+ fermented servings/week, reduced UPF — these three deliver the most.
5. Sleep, movement, stress combined give 15–25% diversity benefit. Neither substitutes for the others. Consistency > intensity.
6. Probiotics only work indication-specifically. A generic "gut-friendly" pill is not a medication. S. boulardii for AB, B. infantis 35624 for IBS-D, VSL#3 for pouchitis — these have strain-level evidence; the rest is just marketing.
7. Antibiotics have the most dramatic microbiome effect of any drug, but when needed they save lives. Distinguishing indicated from unindicated AB is a medical differential-diagnostic task.
8. Most home microbiome tests are acceptable as curiosity but insufficient for clinical decisions. Targeted markers (calprotectin, H. pylori, SIBO breath test) are worth more in a specialist's hands.
9. Red flags always override everything. Blood in stool, unintentional weight loss, nocturnal symptoms, family history — see a doctor, not self-experimentation. VII.5 (When to See a Doctor) details.
10. The future isn't 1 year — it's 10. The realistic timeline for new microbiota tools entering clinical practice (Vowst, targeted prebiotics, engineered probiotics) is the 2030s. Wait patiently and don't pay premium prices without clinical validation.

Decision algorithm by profile

Four common profiles, each with 5–7 concrete steps.

Profile A: "I'm healthy and want to optimize"

The "I'm fine but want to be better" path. Most cost-effective entry.

Reading order: 4 → 5 → 8 (your life stage) → 2 (if mechanisms interest you)

Concrete steps:

1. One-week diet audit: count how many different plant species you eat in a week. Target: 30+. If under 15, aim for 20 next week.
2. Fiber intake: if under 20 g/day, +5 g per week until reaching 25–35 g.
3. 5+ fermented servings/week: kefir, live-culture yogurt, sauerkraut, kimchi, kombucha. See VII.3 (Food Reference).
4. Sleep window: consistent bed-wake (±30 min, weekends too). 7+ hours target, with as much overlap as possible with the repair window.
5. Movement: a 30-min daily walk or 3× 20 min of moderate intensity per week.
6. Daily 5–10 min breathwork/meditation: morning or before bed. See VII.4 (Lifestyle Checklists).
7. Optional: start with 12:12 TRE; progress to 14:10 after 2–3 weeks.

What not to do: don't pay for a home microbiome test. Don't start with a "gut-friendly" probiotic pill. Don't fall into the "detox" trap.

Profile B: "I live with symptoms (bloating, IBS-like, GI complaints)"

The most common profile — and the most often mistreated.

Reading order: 3 (IBS section) → 10 (when to test) → 4 → 11 (probiotic table)

Concrete steps:

1. Red-flag check (VII.5 — When to See a Doctor): blood in stool, weight loss, nocturnal symptoms, family history. If any are yes → urgent gastroenterology, NOT self-experimentation.
2. GP consultation and calprotectin (chapter 10): for IBD flare vs. IBS differentiation.
3. If calprotectin is low and IBS-like picture: subtype-matched probiotic for 4–8 week trial (see chapter 11 table). For IBS-D B. infantis 35624, for bloating L. plantarum 299v. If unsuccessful, a microbiota transfer can be attempted.
4. Low-FODMAP trial with a dietitian (NOT solo — the reintroduction phase matters for microbiome diversity).
5. Consider SIBO breath test if low-FODMAP doesn't improve (chapter 10). The result must be interpreted in context.
6. Stress management (chapter 5) — often weighs as much in IBS as probiotic selection.

What not to do: don't start random probiotics, don't eliminate whole food groups without a clinician, don't do a home microbiome test before GP consult.

Profile C: "I have a diagnosis (IBD, T2DM, IBS, CRC risk, allergy, autoimmune, neurological)"

The profile requiring the most careful planning. Microbiome is adjunct — never a replacement for primary treatment.

Reading order: 3 (your disease group) → 7 (drug interactions) → 11 (therapeutic toolbox) → 4 → VII.5 (When to See a Doctor)

Concrete steps:

1. Read your disease group's evidence level in chapter 3. It tells you what to realistically expect.
2. Treating physician / specialist — coordinate any microbiota-directed step with a microbiota specialist. Don't discontinue prescribed medication on your own.
3. Read chapter 7 for your specific drug's microbiome interactions (PPI, NSAID, metformin, antipsychotic, hormonal, chemotherapy).
4. Specific probiotic only if indication-appropriate (see chapter 11). E.g., E. coli Nissle 1917 or VSL#3 for IBD remission maintenance — approved by the treating physician.
5. Diet — with a clinical dietitian for IBD, IBS, celiac disease.
6. Lifestyle — sleep, movement, stress (chapter 5) often weigh as much as probiotic.
7. Red-flag monitoring (VII.5 — When to See a Doctor) — living with a diagnosis demands even more vigilance.

What not to do: don't discontinue treatment for a microbiota strategy. Don't try FMT for indications other than C. difficile outside a clinical trial.

Profile D: "I'm coming off an antibiotic course"

The most common acute situation — and the most often mistreated.

Reading order: 7 (recovery protocol) → 11 (probiotic table for AAD) → 4

Concrete steps:

1. During and after AB: S. boulardii CNCM I-745 500 mg/day OR L. rhamnosus GG 10⁹–10¹⁰ CFU/day. Start with AB day 1, continue +3 days after the AB course — only if the AB-induced diarrhea doesn't resolve.
2. Continuous hydration and high-fiber diet (chapter 4) — for microbiota recovery.
3. 5+ fermented servings/week during the 2–6 weeks after the AB course.
4. Stress reduction — AB + infection together impose stress; stress level matters for recovery.
5. Persistent diarrhea 2 weeks after AB? C. difficile test — chapter 7.
6. 6-week post-course clinical review — if symptoms (bloating, irregular bowel) linger.
7. If the patient is a child or elderly, extra attention and pediatrician/geriatrician consult.

What not to do: don't stop the AB course earlier than indicated. Don't start with a generic "gut-friendly" probiotic — strain-specific needed. Don't ignore persistent diarrhea — C. difficile is possible.

Optional 30-day plan

For those wanting structured onboarding, a 4-week sample. Not mandatory — a frame for Profile A or D.

Week 1: What to avoid

• Cut weekly UPF intake by 50%
• Avoid artificial sweeteners (one-week trial)
• Avoid late-night meals (last meal before 19:00)

Week 2: Prebiotic + fermented

• Introduce 1 fermented serving/day (kefir/yogurt/sauerkraut)
• 3 legume servings/week (beans, lentils, chickpeas)
• Add 5–10 g inulin/FOS weekly (titrate up)

Week 3: Sleep + stress

• Consistent sleep window
• 1-hour screen reduction before bed
• Daily 5–10 min breathwork
• Weekly nature walk

Week 4: Movement + optional TRE

• 30 min daily walk or 3× moderate-intensity sessions weekly
• Optional 12:12 → 14:10 TRE

New habits only consolidate after 4 weeks; don't quit after the 30-day plan — keep what works.

Continuing the book

Working with material like this is rarely linear: most readers return to specific chapters a few weeks or months later, often triggered by a new symptom, a life-stage milestone, or a clinical consultation. The subsections below mark three moments — when it pays to reread, what to do if you want to go deeper in certain areas, and how to integrate this knowledge into longer-term health decisions. The goal is not to "tick off" the book but to build a reference base you can return to whenever needed.

When to reread

• After a new diagnosis: chapter 3 evidence map, plus your specific disease group
• Before/after antibiotic course: chapters 7 and 11
• Pregnancy, new infant: chapter 8
• Starting a new drug: chapter 7
• Annual review: chapters 1 and 12 — reminder of key takeaways

Further reading

• VII.2 (References) reference list and further reading
• Local and international professional resources (gastroenterology societies, ISAPP)
• Recent research from trustworthy sources (PubMed, ScienceDirect)

Reaching the book's authors

The MicroBiome Bank team continuously updates the book on new evidence. The current version has built a new frame, with the following updates:

• Integration of new RCTs
• Expanded local clinical-practice data
• Clinical validation of next-generation tools (Vowst, HospBiome/DiffBiome, targeted prebiotics) as it becomes available

What you can do tomorrow

Just one thing. Pick one item from the lists above — one food, one habit, one step — and do it tomorrow. The rest can come next week.

Your microbiome will wait until next year. But the good news: if you start one consistent step today, a difference will be measurable by the end of next month.

Acknowledgments

The book's three authors (Patay M.D., Bezzegh M.D., Munar M.D.) and the MicroBiome Bank team thank you for reading. A book has value only when its reader actually uses it. If the content helped, share it with those who could benefit.

We openly welcome feedback and questions. This book is a living document — it evolves because science itself evolves.